Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/1999
06/17/1999CA2311681A1 Human interferon-epsilon: a type i interferon
06/17/1999CA2311645A1 Gene family with transformation modulating activity
06/17/1999CA2311283A1 Purification and microsequencing of hyaluronidase isozymes
06/16/1999EP0922762A1 Drug binding protein
06/16/1999EP0922761A1 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method
06/16/1999EP0922228A2 Assaying d-amino acids in body fluids
06/16/1999EP0922225A1 Assay for quantifying arthritic conditions
06/16/1999EP0922111A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways
06/16/1999EP0922107A1 Human kallikrein
06/16/1999EP0922105A2 Infectious papillomavirus pseudoviral particles
06/16/1999EP0922103A1 NEW $i(BRUCELLA) ANTIGENS, RECOMBINANT POLYPEPTIDES, NUCLEIC ACIDS CODING FOR THE SAME AND USE THEREOF IN DIAGNOSTIC AND PROPHYLACTIC METHODS AND KITS
06/16/1999EP0922102A1 Hepatocyte growth factor receptor agonists and uses thereof
06/16/1999EP0922089A1 Detergent compositions comprising antibody controlled lipolytic activity
06/16/1999EP0922059A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
06/16/1999EP0922053A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
06/16/1999EP0921855A1 Isolation of immunoglobulins
06/16/1999EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/16/1999EP0669976B1 Screening method using transcription factor DP-1
06/16/1999EP0491828B1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF
06/16/1999CN1219969A Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same
06/16/1999CN1219968A Antibodies to ED-8 domain of fibronectin, their construction and uses
06/16/1999CN1219967A Glial cell line-derived neurotrophic factor receptor
06/16/1999CN1219882A Concentrated antibody preparation
06/16/1999CN1219881A Caprine arthritis-encephalitis virus provides immunoprotection against HIV-1 infection
06/16/1999CN1219841A DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
06/15/1999US5912338 A genetically engineered rna molecule contianing homologous and heterologous amino acid sequences to hiv; vaccines for hiv
06/15/1999US5912337 Parasitic helminth p22U proteins
06/15/1999US5912336 Dna molecule coding for an iron-controlled protein found in gram-negative bacteria outer membranes; treatment of gonorrhea and meninigitis
06/15/1999US5912327 Treating with low concentrations of chaotropic agents to solubilize protein, diluting solution with 10 to 20 volumes of buffer ph 4.5 to refold protein, recovering protein
06/15/1999US5912326 A recombinant polypeptide that is a receptor ligand for the oncogene, erbb; treatment of central nervous diseases, cardiac arrythmias, and amyotrophic lateral sclerosis
06/15/1999US5912325 A polypeptide which codes for an epitope of an animal growth hormone; animal growth enhancer
06/15/1999US5912233 Methods and peptides for the treatment of non-IgE-mediated diseases
06/15/1999US5912176 Antibodies against a host cell antigen complex for pre and post exposure protection from infection by HIV
06/15/1999US5912172 Endowing lymphocytes with antibody specificity
06/15/1999US5912144 A polypeptide having an amino acid sequence for an immediate early response gene/g protein couplec receptor; anticarcinogenic, antiproliferative and antitumor agents
06/15/1999US5912136 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
06/15/1999US5912133 Isolating primitive hematopoietic cells by binding cells withantibodies specific for fetal liver kinase, a surface receptor protein tyrosine kinase, and separating
06/15/1999US5912131 Peptides produced by digestion of bone collagen with protease and purified to contain a 3-hydroxypyridinium crosslink; also bind to monoclonal antibody 1h11
06/15/1999US5912126 Preserve cellular morphology
06/15/1999US5912123 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
06/15/1999US5912122 A polynucleotide coding for a central nervous system g protein receptor; therapy for neurodegenerative disorders
06/15/1999US5911995 EGF-genistein conjugates for the treatment of cancer
06/15/1999US5911991 Malarial binding site in duffy blood group protein
06/15/1999US5911989 Antibodies
06/15/1999US5911988 Method for treating asthma using SCF antibody
06/15/1999US5911987 Cell surface protein and effector cell bonding reagent
06/10/1999WO1999028502A1 Single chain monoclonal antibody fusion reagents that regulate transcription in vivo
06/10/1999WO1999028489A2 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer
06/10/1999WO1999028488A2 Pseudo-type retroviral vectors with modifiable surface capsid proteins
06/10/1999WO1999028478A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines
06/10/1999WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/10/1999WO1999028471A2 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE
06/10/1999WO1999028470A1 G-protein coupled receptors and uses therefor
06/10/1999WO1999028467A1 Human thyroid protein zsig45 and dna encoding same
06/10/1999WO1999028466A1 Compositions and methods of use of het
06/10/1999WO1999028462A2 Polypeptides and nucleic acids encoding the same
06/10/1999WO1999028457A1 Tsa305 gene
06/10/1999WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999WO1999028447A1 Human rnase h and compositions and uses thereof
06/10/1999WO1999028443A1 Lineage restricted glial precursors from the central nervous system
06/10/1999WO1999028439A2 Erythrovirus and its applications
06/10/1999WO1999028349A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
06/10/1999WO1999028344A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/10/1999WO1999028334A1 Novel genes encoding proteins involved in mitotic checkpoint control and methods of use thereof
06/10/1999WO1999027964A1 Multivalent recombinant antibodies for treating hrv infections
06/10/1999WO1999027963A1 Antibody production methods relating to disruption of peripheral tolerance in b lymphocytes
06/10/1999WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999WO1999027944A1 Prevention and treatment of amyloidogenic disease
06/10/1999WO1999016891B1 Methods of replicating virus in monocyte-derived macrophage cultures
06/10/1999WO1999015658A3 Human regulatory molecules
06/10/1999WO1999015540A3 Method for producing a pentopyranosyl nucleoside
06/10/1999WO1999015158A3 REGULATION OF CELLULAR APOPTOSIS USING MODULATORS OF β-AR RECEPTORS
06/10/1999WO1999014331A3 Cyclin-dependent kinase inhibitors and uses thereof
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999WO1999006545A8 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
06/10/1999WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
06/10/1999WO1999000671A3 Method for identification of tumor antigens with autoantibodies in serum
06/10/1999WO1998004582A8 Isolated peptides derived from mage-2
06/10/1999DE19754622A1 Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität Herbal GntI sequences and use thereof for the production of plants with reduced or lacking N-acetylglucosaminyltransferase I (GnT) activity
06/10/1999DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders
06/10/1999CA2408167A1 Pro243 polypeptides and nucleic acids encoding the same
06/10/1999CA2313028A1 Multivalent recombinant antibodies for treating hrv infections
06/10/1999CA2312920A1 Prevention and treatment of amyloidogenic disease
06/10/1999CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999CA2312478A1 G-protein coupled receptors and uses therefor
06/10/1999CA2312048A1 Human thyroid protein zsig45 and dna encoding same
06/10/1999CA2312002A1 Human rnase h and compositions and uses thereof
06/10/1999CA2311682A1 Lineage restricted glial precursors from the central nervous system
06/10/1999CA2311640A1 Polypeptides and nucleic acids encoding the same
06/10/1999CA2311574A1 Cells expressing anti-fc receptor binding components
06/10/1999CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999CA2309534A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/10/1999CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/09/1999EP0921395A2 Assays for measurement of protein fragments in biological media
06/09/1999EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene
06/09/1999EP0921189A1 Transgenic animal allergy models and methods for their use
06/09/1999EP0920628A1 NOVEL GPIIb/IIIa PLATELET RECEPTORS ASSAY
06/09/1999EP0920518A1 Stimulus-inducible i (kappa)b kinase ikk] signalsome
06/09/1999EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME